Philips reports positive Q3; outlines €288m recall settlement with DoJ

Philips announced a €288 million settlement with the US Department of Justice related to a 2021 recall of 15 million faulty sleep apnea devices from its Respironics subsidiary. The settlement resolves regulatory enforcement action tied to the recall, which affected respiratory and sleep diagnostic equipment. Philips also reported positive third-quarter financial results.